Movement Alert｜Stryker Overnight Decline 7.77%, Q2 Earnings Beat but Full-Year Guidance Raise Disappoints Market

Market Focus

Jul 31

On July 31, Stryker declined 7.77% overnight, trading at $321.01/share. The sell-off was triggered by the company's second-quarter earnings release after the close on July 30, where strong results were overshadowed by a minimal full-year guidance increase.

Stryker reported Q2 adjusted EPS of $3.69, beating the consensus estimate of $3.49 by 5.73% and representing a 17.89% year-over-year increase from $3.13. Net sales reached $6.589 billion versus the $6.579 billion estimate. Despite the significant Q2 outperformance, the company only narrowed its full-year adjusted EPS guidance to $14.95-$15.10 from the prior range of $14.90-$15.10, against the FactSet estimate of $14.97. The negligible upward revision raised concerns about growth sustainability in the second half.

Market sentiment was further weighed by lingering uncertainty from a Q1 cybersecurity incident that previously caused earnings to miss estimates, with Q1 adjusted EPS of $2.60 falling short of the $2.98 consensus. Investors remain cautious about operational stability heading into the back half of the year.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/1108776904"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1108776904\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1108776904?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-31 08:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1108776904","market":"hk","top_or_hot":-1,"title":"Movement Alert｜Stryker Overnight Decline 7.77%, Q2 Earnings Beat but Full-Year Guidance Raise Disappoints Market","media":"Market Focus","content":"<p><p>On July 31, Stryker declined 7.77% overnight, trading at $321.01/share. The sell-off was triggered by the company's second-quarter earnings release after the close on July 30, where strong results were overshadowed by a minimal full-year guidance increase.</p><p>Stryker reported Q2 adjusted EPS of $3.69, beating the consensus estimate of $3.49 by 5.73% and representing a 17.89% year-over-year increase from $3.13. Net sales reached $6.589 billion versus the $6.579 billion estimate. Despite the significant Q2 outperformance, the company only narrowed its full-year adjusted EPS guidance to $14.95-$15.10 from the prior range of $14.90-$15.10, against the FactSet estimate of $14.97. The negligible upward revision raised concerns about growth sustainability in the second half.</p><p>Market sentiment was further weighed by lingering uncertainty from a Q1 cybersecurity incident that previously caused earnings to miss estimates, with Q1 adjusted EPS of $2.60 falling short of the $2.98 consensus. Investors remain cautious about operational stability heading into the back half of the year.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Stryker Overnight Decline 7.77%, Q2 Earnings Beat but Full-Year Guidance Raise Disappoints Market</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Stryker Overnight Decline 7.77%, Q2 Earnings Beat but Full-Year Guidance Raise Disappoints Market\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-31 08:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 31, Stryker declined 7.77% overnight, trading at $321.01/share. The sell-off was triggered by the company's second-quarter earnings release after the close on July 30, where strong results were overshadowed by a minimal full-year guidance increase.</p><p>Stryker reported Q2 adjusted EPS of $3.69, beating the consensus estimate of $3.49 by 5.73% and representing a 17.89% year-over-year increase from $3.13. Net sales reached $6.589 billion versus the $6.579 billion estimate. Despite the significant Q2 outperformance, the company only narrowed its full-year adjusted EPS guidance to $14.95-$15.10 from the prior range of $14.90-$15.10, against the FactSet estimate of $14.97. The negligible upward revision raised concerns about growth sustainability in the second half.</p><p>Market sentiment was further weighed by lingering uncertainty from a Q1 cybersecurity incident that previously caused earnings to miss estimates, with Q1 adjusted EPS of $2.60 falling short of the $2.98 consensus. Investors remain cautious about operational stability heading into the back half of the year.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SYK","symbol_name":"史赛克","start_time":0,"source_url":"","article_id":"1108776904","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1108776904","pubTimestamp":1785456404,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 31, Stryker declined 7.77% overnight, trading at $321.01/share. The sell-off was triggered by the company's second-quarter earnings release after the close on July 30, where strong results...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SYK":"史赛克"},"translate_title":"走势警报|史赛克隔夜下跌7.77%，第二季度盈利超出预期，但全年指引上调令市场失望","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SYK":1},"content_text":"On July 31, Stryker declined 7.77% overnight, trading at $321.01/share. The sell-off was triggered by the company's second-quarter earnings release after the close on July 30, where strong results were overshadowed by a minimal full-year guidance increase.Stryker reported Q2 adjusted EPS of $3.69, beating the consensus estimate of $3.49 by 5.73% and representing a 17.89% year-over-year increase from $3.13. Net sales reached $6.589 billion versus the $6.579 billion estimate. Despite the significant Q2 outperformance, the company only narrowed its full-year adjusted EPS guidance to $14.95-$15.10 from the prior range of $14.90-$15.10, against the FactSet estimate of $14.97. The negligible upward revision raised concerns about growth sustainability in the second half.Market sentiment was further weighed by lingering uncertainty from a Q1 cybersecurity incident that previously caused earnings to miss estimates, with Q1 adjusted EPS of $2.60 falling short of the $2.98 consensus. Investors remain cautious about operational stability heading into the back half of the year.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}